NCT05267496Active, not recruiting
Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery
Effect of Oscillating Positive Expiratory Pressure Therapy on the Frequency of Pulmonary Atelectasis in Thoracic Cancer Patients Undergoing Chest Surgery
Source: ClinicalTrials.gov · Last updated 8 Apr 2026
Brief summary (registry, in English)
This randomized clinical study aims to assess the use of an oscillating positive expiratory pressure device (AEROBIKA) in patients with thoracic neoplasms who undergo chest surgery. The main questions it aims to answer are: If the use of the AEROBIKA device reduces the incidence of atelectasis in oncological patients undergoing lung resection. If the use of the AEROBIKA device reduces hospital readmission and days of hospital stay. Participants who accept to participate will be sorted to receive a conventional rehab therapy (group A), otherwise a conventional rehab therapy plus AEROBIKA device (group B). Researchers will compare patients from group A versus group B to see if patients develop atelectasis.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 72 (actual)
- First submitted
- 24 Feb 2022
- Start date
- 13 Aug 2019
- Primary completion date
- 28 Feb 2023
- Lead sponsor
- Instituto Nacional de Cancerologia de Mexico
- Diseases
- Lung cancer
- NCT number
- NCT05267496
What you commit to
- Study type: Interventional
- Participants enrolled: 72
- From 13 Aug 2019 to the primary completion date, 28 Feb 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Esophagus surgery
Other illness
- Unstable systemic disease, including active infection, cardiac or hemodynamic diseases or neurological diseases.
- Patients with cognitive impairment who are not able to perform the pulmonary rehabilitation exercises.
Other
- Oral cavity or facial trauma.
- Active hemoptysis
- Tympanic rupture or middle ear pathology.
Who the study is looking for
- Patients with a confirmed diagnosis of lung cancer, mediastinal tumors or mesothelioma who are candidates for surgical resection through thoracotomy or sternotomy.
- Measurable disease
- Age from 18 to 75 years
- Peak Expiratory flow of 10 liters/min
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- Karnofsky score 70-100
- Patients willing and able to comply with all study procedures and follow-up visits.
- Patients who agree to participate and sign an informed consent form
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Nacional de Cancerologia Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.